CA 125 levels in patients with ovarian carcinoma undergoing autologous bone marrow transplantation
Related Experiment Videos
N Ciobanu1, C D Runowicz, P H Wiernik
1Department of Oncology, Montefiore Medical Center/Albert Einstein Cancer Center, Bronx, NY 10467.
American Journal of Obstetrics and Gynecology
|February 1, 1989
Abstract:
Levels of CA 125, determined in three patients with ovarian carcinoma undergoing autologous bone marrow transplantation, dropped significantly in the month after bone marrow transplantation. This decrease was linear by multiple regression analysis. The CA 125 decrease after bone marrow transplantation in patients with nonevaluable or stable disease may represent biologic response to high-dose therapy.